Duramed Pharmaceuticals, Inc. v. Schein Pharmaceuticals
We were lead counsel for Schein Pharmaceutical in litigation brought by Duramed Pharmaceuticals concerning the conjugated estrogens drug sold as "Cenestin." After extensive discovery and motion practice, the case settled shortly before trial in 2000 with Duramed paying Schein $15 million and agreeing to pay an additional $15 million if certain profit milestones for Cenestin were met. Duramed Pharmaceuticals, Inc. v. Schein Pharmaceuticals, Case No. A9705498 (Hamilton County Court of Common Pleas)